Survey on the SARS-CoV-2 additional vaccination

Survey on the transition of SARS-CoV-2 serum antibody titer and health condition with the SARS-CoV-2 additional vaccination: COVID-19 research

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1061210049

Enrollment

1500

Registered

2021-11-12

Start date

2021-11-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: School staff who are participating in jRCT1061200057 research and receive the additional SARS-CoV-2 vaccination in December 2021

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Transition of SARS-CoV-2 serum antibody titer after the SARS-CoV-2 additional vaccination	—

Secondary

Measure	Time frame
Transition ofHealth condition after the SARS-CoV-2 additional vaccination Backgroud factor that is contribute transition of SARS-CoV-2 serum antibody titer	—

Contacts

Public ContactShin Ohira

Kawasaki Medical School Hospital

ohira@med.kawasaki-m.ac.jp+81-86-462-1111

Outcome results